person
Christian G.
- Country
- Germany
- Department
- -
Research Overview
assignment
52
Clinical Trials ·
- Phase 2 Study of ABBV-706 and Atezolizumab versus Standard of Care in Patients with Previously Untreated Extensive-Stage Small Cell Lung Cancer
- Phase 2 Open‑Label Multicohort Study of Rinatabart Sesutecan Monotherapy in Patients with Locally Advanced or Metastatic Non‑Small Cell Lung Cancer
- Phase 3 Randomized Open‑Label Study of ZL‑1310 versus Investigator‑Chosen Topotecan in Relapsed Small Cell Lung Cancer
location_city
2
Research Sites
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
429
Sites with multiple studies
Has run more than one trial at 429 of 708 partner sites.
Specializations
Lung Cancer Therapeutics
The investigator specializes in treating non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), with particular focus on advanced and metastatic disease states.
- NSCLC Treatment Approaches
- SCLC Therapeutic Interventions
- Metastatic Disease Management
Immunotherapy Applications
Expertise in novel immunotherapy combinations and targeted treatments, including work with PD-L1 inhibitors and various therapeutic antibodies for lung cancer treatment.
- Immunotherapy Combinations
- Targeted Therapy Development
- Treatment Resistance Management
Respiratory Conditions
Additional focus on nontuberculous mycobacterial lung infections and idiopathic pulmonary fibrosis, exploring innovative treatment approaches and therapeutic solutions.
- Mycobacterial Infection Treatment
- Pulmonary Fibrosis Management
- Respiratory Disease Interventions
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.